#Downgrades - Dec 05, 2024 • $ABBV: Daiwa Securities Downgrades to Neutral from Buy - PT $180 • $AEO: JPMorgan Downgrades to Neutral from Overweight - PT $23 (from $27) • $ALLY: Wolfe Research Downgrades to Peerperform from Outperform • $AMAT: Morgan Stanley Downgrades to Underweight from Equalweight - PT $164 (from $179) • $CHWY: BNP Paribas Downgrades to Neutral from Outperform - PT $30 • $CNX: JPMorgan Downgrades to Underweight from Neutral - PT $37 (from $31) • $DVN: JPMorgan Downgrades to Neutral from Overweight - PT $191 • $F: Wolfe Research Downgrades to Underperform from Peerperform • $FOUR: Benchmark Downgrades to Hold from Buy • $FWONA: Seaport Global Securities Downgrades to Neutral from Buy • $GRAB: HSBC Downgrades to Hold from Buy - PT $5.50 (from $4.25) • $MRVI : Goldman Sachs Downgrades to Sell from Neutral - PT $4.25 (from $7) • $NAUT: Goldman Sachs Downgrades to Sell from Neutral - PT $1.75 (from $2.25) • $NCNO: Piper Sandler Downgrades to Neutral from Overweight - PT $38 • $OTIS: Barclays Downgrades to Underweight from Equalweight - PT $94 • $PB: Wolfe Research Downgrades to Peerperform from Outperform • $PFG: Morgan Stanley Downgrades to Underweight from Equalweight - PT $80 (from $86) • $RLMD: Mizuho Downgrades to Neutral from Outperform - PT $1 (from $23) • $ROP: Barclays Downgrades to Underweight from Overweight - PT $569 (from $625) • $SBRA: Mizuho Downgrades to Neutral from Outperform - PT $20 • $SM: JPMorgan Downgrades to Neutral from Overweight - PT $16 (from $15) • $VCYT: Goldman Sachs Downgrades to Neutral from Buy - PT $37 (from $38)

MORNING RECAP • Target Corp. ( $TGT): Shares fell after Q3 results missed expectations; EPS $1.85 vs. $2.30 est., sales up 0.9% to $25.23B missing $25.74B est., and operating margin at 4.6% vs. 5.6% est. FY EPS guidance lowered to $8.30-$8.90 from $9-$9.70. • Azek Company ( $AZEK): Beat Q4 expectations with EPS at $0.29 vs. $0.27 est., adjusted EBITDA $91.8M vs. $88.1M, and sales at $348.22M. FY25 guidance: revenue $1.51B-$1.54B, adjusted EBITDA $400M-$415M. • Chewy ( $CHWY): Upgraded to 'Buy' by Bank America with price target raised to $40 from $24. • Delta Air Lines ( $DAL): Projects mid-single digit revenue growth for 2025, with capacity expansion up to 4%. • La-Z-Boy ( $LZB): Q2 EPS $0.71 vs. $0.64 est., sales up 1.9% to $521M, Q3 guidance provided, dividend raised to $0.22. • Uber ( $UBER): Launched Uber XXL for airport travel in 60+ airports and new reservation features with flight tracking. • AeroVironment ( $AVAV): Upgraded to Buy from Hold by Jefferies. • DT Midstream ( $DTM): Acquires three pipelines from Oneok for $1.2B, spanning 1,300 miles across seven Midwest states. • Dycom ( $DY): Q3 EPS $2.68 vs. $2.26 est., revenue $1.27B vs. $1.22B est.; anticipates mid- to high single-digit revenue growth in Q4. • Patrick Industries ( $PATK): Announces a 3-for-2 stock split. • Powell Industries ( $POWL): Q4 revenue up 32.1% to $275.1M, but missed $284.3M est.; EPS $3.77 vs. $3.55 est.; orders up 56% to $267M, backlog steady at $1.3B, expects strong FY25. • SolarEdge ( $SEDG): Upgraded to Neutral from Sell by Guggenheim, previous $10 price target dropped. • Forestar Group ( $FOR): Files for potential sale of up to $300M in common stock. • JPMorgan ( $JPM): Downgraded to Perform from Outperform by Oppenheimer due to valuation. • Lemonade ( $LMND): Upgraded to equal weight from underweight by Morgan Stanley post-investor day. • StoneX Group ( $SNEX): Q4 EPS $2.32 vs $2.05 est., net revenue $454.8M vs $462.98M est. • XP Inc. ( $XP): Launches a buyback program up to R$1.0B; Q3 EPS as expected at 2.18, revenue slightly below at 4.319B; active clients increased to 4.7M. • Concentra Group Holdings Inc. ( $CON) will replace Myers Industries Inc. (MYE) in the S&P SmallCap 600 on November 27, following a distribution by Select Medical Holdings Corp. (SEM). • Pfizer ( $PFE) appointed Chris Boshoff as its R&D chief starting January 1. It also received EC approval for Hympavzi for hemophilia treatment. • Sangamo Therapeutics ( $SGMO) received FDA clearance for ST-503 human trials, with enrollment planned for mid-2025. • Varex Imaging ( $VREX) reported Q4 EPS at $0.19, beating the $0.09 estimate, but revenue dropped 10% to $205.7M. Forecasts Q1 revenue between $195M-$215M. • Viking Therapeutics ( $VKTX) shared positive mid-stage trial results for VK2809, showing significant improvement in liver fibrosis over placebo. • Comcast Corp. ( $CMCSA) is set to spin off cable channels like MSNBC, CNBC, and USA to reduce exposure to declining viewership and ad revenue, keeping NBC and Peacock, per WSJ. • Dolby Labs ( $DLB) Q4 EPS $0.81 vs. $0.70 est., revenue slightly below at $305M. Forecasts Q1 revenue $330-360M and FY revenue $1.33-1.39B. • Flex Ltd ( $FLEX) will replace Azenta Inc. ( $AZTA) in S&P MidCap 400, with Azenta moving to S&P SmallCap 600, effective November 25. • Keysight Technologies (KEYS) Q4 EPS $1.65 vs. $1.57 est., revenue at $1.287B. Q1 guidance: revenue $1.265-1.285B, EPS $1.65-1.71. • https://t.co/jK5z8CZLV2 ( $WIX) Q3 EPS $1.62 vs. $1.51 est., revenue $444.67M vs. $457.9M est. Increases FY24 revenue and bookings forecasts. • ZoomInfo Technologies ( $ZI) Chairman Schuck purchased 492,500 shares at $10.25 each on November 15, transaction worth $5,049,750.

#Upgrades - Nov 20, 2024 • $AVAV: Jefferies Upgrades to Buy from Hold - PT $230 (from $240) • $CHWY: BofA Securities Upgrades to Buy from Underperform - PT $40 (from $24) • $ENR: JPMorgan Upgrades to Neutral from Underweight - PT $39 (from $32) • $GLPI: Deutsche Bank Upgrades to Buy from Hold - PT $54 (from $49) • $INSP: BofA Securities Upgrades to Buy from Underperform - PT $255 (from $220) • $LMND: Morgan Stanley Upgrades to Equalweight from underweight - PT $42 (from $23) • $NWL: Barclays Upgrades to Overweight from Equalweight - PT $10 (from $8) • $SEDG: Guggenheim Upgrades to Neutral from Sell • $XPEV: CMB International Securities Upgrades to Buy from Hold - PT $16 (from $8)

We're thrilled to announce that the @CHEWY_CHWY Kickstarter has concluded and $CHWY will be listed on #MEXC! 🔹Deposit: Opened 🔹CHWY/USDT Trading in Innovation Zone: 2024-09-02 14:00 (UTC) Details:

.@CHEWY_CHWY, a meme coin on the Solana chain, is coming to #MEXCKickstarter 🚀 🗳Vote with $MX to share massive airdrops 📈 $CHWY/USDT Trading: 2024-09-02 14:00 (UTC) Details:

Underrated CTO… $GIL is COOKING! 🧑‍🍳

$CHWY Good Game

热度事件： $CHWY 目前市值： $1.3M 受到情绪推动， 该同名代币收到广泛关注。 0xce176825afc335d9759cb4e323ee8b31891de747

$CHWY 3❌ 三天前咆哮小猫发送的推文，买入即被套。被套福利…

$CHWY CHEWY SHARES RALLY 20% AFTER SEC FILING REVEALS ‘ROARING KITTY’ KEITH GILL HAS 6.6% STAKE

赌博这个 $chwy

$CHWY 又是一样的情节，自咆哮小猫发出后，宠物食品公司CHWY在20分钟内上涨了📈接近20%。 这家宠物食品公司是由GME的CEO，Ryan Cohen创立。 这次是动物园，SOL上的 $CHWY 市值目前为3.8M，ETH上的自我上篇推文发送已经2x，目前1.6M。 目前来看，美股CHWY已经在回落，可以找位置上车meme。

那个图片为什么跟 $chwy 有关啊？科普一下

$CHWY SOL: 2zGQGkLnQgWLvfSiWTXnnxdMA7fiP4ah6hyJPQQe3Eoe ETH: 0xce176825afc335d9759cb4e323ee8b31891de747

$CHWY 2zGQGkLnQgWLvfSiWTXnnxdMA7fiP4ah6hyJPQQe3Eoe

兄弟们啊？？？？？？啊啊啊啊？？？？？ $chwy 我买的时候4000u市值，在pump里面，我找了一个没人要的 $chwy 刚刚涨了最高300倍！！！！？？啊啊啊，我以前的钱包里面还有没有这个币？？？？大家有没有监控帮我看看！！！我草啊

$CHWY SPIKE +12% FOLLOWING TWEET FROM "ROARING KITTY"